These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12543979)

  • 1. Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice.
    Tang Y; Katuri V; Dillner A; Mishra B; Deng CX; Mishra L
    Science; 2003 Jan; 299(5606):574-7. PubMed ID: 12543979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.
    Mishra B; Tang Y; Katuri V; Fleury T; Said AH; Rashid A; Jogunoori W; Mishra L
    Liver Int; 2004 Dec; 24(6):637-45. PubMed ID: 15566516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonic liver fodrin involved in hepatic stellate cell activation and formation of regenerative nodule in liver cirrhosis.
    Wang Z; Liu F; Tu W; Chang Y; Yao J; Wu W; Jiang X; He X; Lin J; Song Y
    J Cell Mol Med; 2012 Jan; 16(1):118-28. PubMed ID: 21388516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation.
    Kitisin K; Ganesan N; Tang Y; Jogunoori W; Volpe EA; Kim SS; Katuri V; Kallakury B; Pishvaian M; Albanese C; Mendelson J; Zasloff M; Rashid A; Fishbein T; Evans SR; Sidawy A; Reddy EP; Mishra B; Johnson LB; Shetty K; Mishra L
    Oncogene; 2007 Nov; 26(50):7103-10. PubMed ID: 17546056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
    Yuan W; Varga J
    J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis.
    Tang Y; Katuri V; Srinivasan R; Fogt F; Redman R; Anand G; Said A; Fishbein T; Zasloff M; Reddy EP; Mishra B; Mishra L
    Cancer Res; 2005 May; 65(10):4228-37. PubMed ID: 15899814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-2 spectrin is involved in hepatocyte proliferation through the interaction of TGFβ/Smad and PI3K/AKT signalling.
    Wang Z; Song Y; Tu W; He X; Lin J; Liu F
    Liver Int; 2012 Aug; 32(7):1103-11. PubMed ID: 22541060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.
    Piek E; Ju WJ; Heyer J; Escalante-Alcalde D; Stewart CL; Weinstein M; Deng C; Kucherlapati R; Bottinger EP; Roberts AB
    J Biol Chem; 2001 Jun; 276(23):19945-53. PubMed ID: 11262418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression.
    Katuri V; Tang Y; Li C; Jogunoori W; Deng CX; Rashid A; Sidawy AN; Evans S; Reddy EP; Mishra B; Mishra L
    Oncogene; 2006 Mar; 25(13):1871-86. PubMed ID: 16288220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
    Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
    EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
    Feng XH; Lin X; Derynck R
    EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.
    Wicks SJ; Lui S; Abdel-Wahab N; Mason RM; Chantry A
    Mol Cell Biol; 2000 Nov; 20(21):8103-11. PubMed ID: 11027280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
    Fink SP; Mikkola D; Willson JK; Markowitz S
    Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear targeting of transforming growth factor-beta-activated Smad complexes.
    Chen HB; Rud JG; Lin K; Xu L
    J Biol Chem; 2005 Jun; 280(22):21329-36. PubMed ID: 15799969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta induces nuclear import of Smad3 in an importin-beta1 and Ran-dependent manner.
    Kurisaki A; Kose S; Yoneda Y; Heldin CH; Moustakas A
    Mol Biol Cell; 2001 Apr; 12(4):1079-91. PubMed ID: 11294908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation.
    Prunier C; Pessah M; Ferrand N; Seo SR; Howe P; Atfi A
    J Biol Chem; 2003 Jul; 278(28):26249-57. PubMed ID: 12732634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.